Outcomes of infants born to persons infected with Hepatitis B virus and managed by the CDC Perinatal Hepatitis B Prevention Program, by birth cohort year — 56 US Jurisdictions,* 2009–2020

Print
Related Pages
◀ Perinatal Hepatitis B
Table 4.1 ▶

Outcomes of infants born to persons infected with Hepatitis B virus and managed by the CDC Perinatal Hepatitis B Prevention Program, by birth cohort year — 56 US Jurisdictions,* 2009–2020

Download Data (xlsx)

Source: CDC, National Perinatal Hepatitis B Prevention Program (PHBPP). Infants managed: Number of infants case managed by the PHBPP.
PEP (postexposure prophylaxis): Number of infants who received PEP (hepatitis B immune globulin and 1st dose of hepatitis B vaccine) for hepatitis B virus infection.
PVST (postvaccination serological testing): Number of infants who received PVST after hepatitis B vaccine series completion.
* Includes 50 states, District of Columbia, and five cities. Excludes territories and freely associated island nations.

The number of infants whose care was managed in the CDC Perinatal Hepatitis B Prevention Program from 50 states, District of Columbia, and five cities was 11,551 in 2009 and 7,583 in 2020. During 2009–2020, the percentage of infants who received PEP has remained relatively stable between 95% to 97% each year. The percentage of infants who received PVST has increased from 59% (6,792 of 11,551 infants managed) in 2009 to 65% (4,960 of 7,583 infants managed) in 2020.

Perinatal Hepatitis B Figures and Tables

Table 4.1. Outcomes of infants born in 2021 to persons infected with hepatitis B virus and managed by CDC Perinatal Hepatitis B Prevention Program through the end of 2022 — 64 US Jurisdictions

Figure 4.1. Outcomes of infants born to persons infected with hepatitis B virus and managed by CDC Perinatal Hepatitis B Prevention Program (PHBPP), by birth cohort year — 56 US Jurisdictions, 2009–2021